Evidence map›Paper›PMID 42499467›Full record

ArticleAnnals of Ibadan postgraduate medicine2026

FAMILIAL CARDIOMYOPATHY IN NIGERIA: A CASE REPORT.

O S Ogah, O S Folayan, A Aje, O F Ashubu, O A Orimolade, O O Ademowo-Olusanya, A Adebiyi

Abstract read
In one paragraph

Article in Annals of Ibadan postgraduate medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

O S OgahDepartment of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria.
O S FolayanInstitute of Cardiovascular Diseases, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria.
A AjeCardiology Unit, Department of Medicine, University College Hospital, Ibadan, Nigeria.
O F AshubuDepartment of Paediatrics, Faculty of Clinical Sciences, College of Medicine, University College Hospital, Ibadan, Nigeria.
O A OrimoladeInstitute of Cardiovascular Diseases, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria.
O O Ademowo-OlusanyaCardiology Unit, Department of Medicine, University College Hospital, Ibadan, Nigeria.
A AdebiyiDepartment of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Familial DCM (FDCM) is identified when two or more firstdegree relatives have idiopathic dilated cardiomyopathy (DCM) or unexplained death at a young age. This report aims to highlight the clinical manifestations of FDCM in a Nigerian family, emphasizing the importance of genetics while addressing the paucity of local data. Case Presentation: This report describes a 22-year-old male with DCM whose elder sibling died from DCM, and a younger one had similar echocardiographic features as the index patient, highlighting the hereditary nature of the disease within his family The patient, initially asymptomatic, reported easy fatigability, breathlessness, and cough, which worsened over three months. Clinical examinations revealed signs of advanced heart failure, including elevated jugular venous pressure and fine bibasal crepitations. Echocardiography confirmed DCM. Despite initial treatment, the patient developed an intracardiac clot and required an extensive medication regimen. Family history indicated an autosomal dominant inheritance pattern, with a younger sibling also showing features of DCM. Conclusion: This case underscores the importance of genetic factors in the pathogenesis of FDCM and highlights the challenges of managing the disease, particularly in resource-limited settings. Early family screening, patient education, and adherence to treatment protocols are crucial for improving outcomes. There is a need for accessible genetic testing to facilitate early diagnosis and intervention in at-risk populations.

Indexed as

Familial cardiomyopathyGenetic predispositionGeneticsHeart failureInherited heart disease

Identifiers

PMID42499467
PMCPMC13399423

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.